Navigating Novel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies for Advance Practice Providers

Hematopoietic stem cell transplant (HSCT) and cellular therapy is a hyper-specialized field within the already specialized pediatric oncology world. This necessitates providers to stay current on the rapidly evolving science behind the care of these complex patients.

This one-day symposium will have a focus on topics curated for advanced practice providers, including a mix of foundations of HSCT in addition to current clinical developments in the field. The focused topics will include advances in GVHD therapies, unique disease processes that are being transplanted more often in the current era, diagnostic findings of HSCT complications, and new clinical trials that our patients are undergoing including JSP for SCID, TCR modified T-cell therapy for sarcoma patients and expanded cord blood transplant for multiply relapsed leukemia.

Who Should Attend

This symposium is intended for advanced practice providers who will be caring primarily or be involved in the care of pediatric hemopoietic stem cell transplant patients.

We are pleased to offer complimentary registration for residents, fellows, APP students, and nursing students to attend this course. Please see details below. 

Live Virtual Symposium

This program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.

IMPORTANT: Access details, including a link to Zoom and more, are in the confirmation email you will receive after registration.

1. Discuss the role of allogeneic hematopoietic stem transplantation in the treatment of both malignant and non-malignant diseases
2. Identify the how and why hematopoietic stem cell transplant conditioning regimens are selected
3. Describe the pathophysiology and clinical management of common hematopoietic stem cell transplant complications and toxicities
4. Gain knowledge of the new advancements in care of pediatric hematopoietic stem cell transplant patients, including new types of transplants and other alternatives such as gene therapy
5. Summarize the mechanism of acute and chronic GVHD including prophylactic strategies, treatment (including new research based therapies) and supportive care

Virtual Registration Fees

• Physicians (MDs, PhDs and DOs): $100
• Advanced Practice Providers: $75
• Nursing and Other Healthcare Professionals: $50 
• Residents, Fellows, APP Students, and Nursing Students*: complimentary; please see below for details 
• Industry Professionals**: $175 

Discounts/Promotions

• *Residents, Fellows, APP Students, and Nursing Students: please email [email protected] to receive a promotion code for complimentary registration.
• A registration discount is available for MSK Alumni, and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
• Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

**Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 7:00 AM on November 2, 2022. If you wish to register after this date, please email [email protected] and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course. 

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Kimberly Dachisen, MSN, FNP-BC, CPHON

Physician Sponsor

Jaap-Jan Boelens, MD, PhD
Chief, Pediatric Stem Cell Transplantation and Cellular Therapies Service
Richard J. O’Reilly Chair in Honor of Kevin Zoltan Merszei

Planning Committee

Jennifer Allen, NP

Linda D'Andrea, MSN, PPCNP-BC

Joanne Torok-Castanza, MSN

Invited Patient Speaker

Samantha Eisenstein Watson

Invited Course Faculty 

Christen Ebens, MD
Assistant Professor
University of Minnesota Masonic Children’s Hospital

Katiana Garagozlo, MD
Clinical Fellow
NewYork-Presbyterian/Weill Cornell Medical Center

Sonata Jodele, MD
Research Professor
Cincinnati Children’s Hospital Medical Center

Parinda Mehta, MD
Professor 
Cincinnati Children’s Hospital Medical Center

Susan Prockop, MD
Program Director for Clinical and Translational Research;
Attending Physician
Boston Children’s Hospital

MSK Course Faculty 

Gerald Behr, MD
Associate Attending Radiologist

Sandra D’Angelo, MD
Associate Attending

Gloria Contrares-Yametti, MD
Clinical Fellow

Andrew Harris, MD
Associate Attending

Alina Markova, MD
Assistant Attending

Morgan Mastin, PharmD
Assistant Attending

Joseph Oved, MD
Assistant Professor

Karen Queliza, MD
Assistant Attending

Andromachi Scaradavou, MD
Associate Attending

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Wednesday, November 2, 2022